Peroxisome proliferator - Activated receptor α as a genetic determinant of cardiac hypertrophic growth culprit or innocent bystander?

Circulation

Volumn 105, Issue 9, 2002, Pages 1025-1027

  Kelly, Daniel P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Editorials; Genetics; Hormones; Hypertrophy; Metabolism

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ALLELISM; DISEASE COURSE; EDITORIAL; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HIGH RISK POPULATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 0037022913     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/circ.105.9.1025     Document Type: Editorial

References (22)

1. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
2. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingham heart study
3. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins: The Medical College of Virginia twin study
4. Relations of left ventricular mass to demographic and hemodynamic variable in American Indians: The strong heart study
5. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism
6. Angiotensin-converting enzyme in the human heart
7. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms
8. Peroxisome proliferator-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension
9. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
10. PPAR signaling in the control of cardiac energy metabolism
11. A role for PPARα in the control of cardiac Malonyl-CoA levels: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of Malonyl-CoA and reduced expression of Malonyl-CoA decarboxylase
12. Mitochondrial fatty acid oxidation disorders
13. Inherited cardiomyopathies
14. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis
15. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
16. Metabolically-modulated growth and phenotype of the rat
17. Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms
18. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
19. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program
20. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
21. Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth
22. A novel mouse model of lipotoxic cardiomyopathy